Position in OGI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,424
-$49,223 QoQ
Shares Held
64,142
-25.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 69 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. OGI ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in OGI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,424 | 64,142 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $114,647 | 85,558 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||